58 results
6-K
ASND
Ascendis Pharma A/S
2 May 24
Current report (foreign)
4:29pm
over time as rendering of services or reimbursement revenue, as applicable.
F-9
For the three months ended March 31, 2024, revenue from “Licenses … , and which will be recognized as revenue over time as rendering of services or reimbursement revenue, as applicable.
At March 31, 2024, none
6-K
EX-99.2
ASND
Ascendis Pharma A/S
2 May 24
Notice to convene Annual General Meeting 2024
4:02pm
and equipment
Reimbursement from acquisition of property, plant and equipment
Purchase of marketable securities
Settlement of marketable securities
Cash flows … to separate remuneration, and which will be recognized as revenue over time as rendering of services or reimbursement revenue, as applicable.
At December 31
6-K
EX-99.3
ASND
Ascendis Pharma A/S
2 May 24
Notice to convene Annual General Meeting 2024
4:02pm
with rare disease are often seen and treated at only a few national centers, we offer reimbursement of travel expenses incurred by trial site visits
S-8
EX-99.2
ASND
Ascendis Pharma A/S
29 Feb 24
Registration of securities for employees
4:29pm
of the Company providing for the reimbursement of incentive compensation, whether or not such policy is in place at the time of grant or payment of the PSUs
6-K
EX-99.1
crpdyku88t nxv3a0u0
8 Jan 24
Current report (foreign)
6:08am
6-K
fdobrf
7 Nov 23
Current report (foreign)
4:03pm
6-K
cdy7yv ex98316jj
5 Sep 23
Current report (foreign)
4:14pm
6-K
EX-99.2
ave8xqwqhes
2 May 23
Notice to convene Annual General Meeting 2023
4:02pm
6-K
7lpaua
27 Apr 23
Current report (foreign)
4:02pm
6-K
v2vtbu32
2 Nov 22
Current report (foreign)
4:31pm
6-K
tcozp0bbmgvsk7q4am0d
10 Aug 22
Current report (foreign)
4:13pm
6-K
EX-99.1
dc2iaq
11 May 22
Current report (foreign)
4:06pm
6-K
EX-99.2
z2s7r95ma9hgi 21qlr5
11 May 22
Current report (foreign)
4:06pm
6-K
EX-99.2
xry8zxu6p2
2 May 22
Notice to convene Annual General Meeting 2022
6:25am
6-K
EX-99.1
14p8x
10 Jan 22
Current report (foreign)
8:24am